beam11 has proved herself "long" (instead of "wrong") in her own posts.

OT

beacon, some people have difficulty rolling their tongue and are unable to pronounce "r" properly. Hence these people would pronounce the word, "WRONG" as "LONG".

Are you "WRONG" with NEOM or
are you "LONG" with NEOM?

LOL

Those people who received the MDFY e-mail yesterday with the PR about MedifyRemote's Vodafone Certified application status may have noticed the News Release sent was with the Vodafone Header and Footer, implying it was a Vodafone News Release!

Brewskih,

Not a problem. I'm glad you got the facts correct now.

brewskih,

Where did you get your information from?

Chas Fritz was definitely the Chairman of the Board, and still is.

Chuck Jensen was never at any time Chairman of the Board!

Does anyone know if Chas was/is an executive Chairman or non-executive Chairman?

solidgold,

That is an excellent question! Just who are the official members of the Board of Directors of MDFY. I want to know this information too!

Where can we find this answer? Is this information officially filed with the SEC or some other authority?

Personally, the only leadership quality I saw in Chas was being a visionary. Please note that I used the past tense.
IMO, even the visionary quality has faded with time.

I agree that his act of selling NEOM shares at a time when the pps was under pressure, showed the selfishness in him. He was concerned only about and for himself, rather than the company and the shareholders. It might even tantamount to betrayal, particularly as the long faithful supporters were trying to support the pps while Chas, as Chairman, sold his shares instead. I do not see him qualified to continue as the leader. In the present situation, though, he cannot and should not just abandon the company and go. As a redemption act, he should identify and put in place a new management team, including credible and qualified new members to the Board of Directors. This may be Chas' saving grace.

Besides Chas, there are still some other senior positions that need to be changed for the better, including one in Finance, which has been one major weakness in this company.
I will refrain from naming names, but I believe it is quite obvious to many whom I am referring to.

Drmyke,

I am not answering this for the person you directed the question to.

Personally, it was "Blind Faith" coupled with "Fat Hopes".
Perhaps, now I am still hanging on because there is little left to lose.

It is such a pity. A company with tremendous potential in its IP, unfortunately in the hands of people who were just not the calibre required to make a success of it.

We hope this will change in 2007 for the better. I am not giving up hope.

kokonutguy and in4it,

Thank you for your responses. There is an initial set up fee of around $5000 (If I recall correctly from somewhere) plus a monthly fee ranging from $300 to a couple of thousand dollars, depending on what the word/s or number/s is/are.

Kokonutguy, your question, compared to what, needs to have an answer available by the NEOM marketing/sales person when talking to a prospect for Word Registry or qode. Was/is NEOM able to convince a prospect that spending $300-$500 per brand word to reach the growing masses of internet-enabled camera cell phone crowd would be unimaginably cheap? (trying to use mostly your words, kokonutguy). What results did NEOM have with its marketing and sales effort?

Is NEOM actively going out marketing and selling this? Or is NEOM waiting in the office for customers to come queing at the door to buy in? What has happened I wonder? Where are the Word Registry customers? Why is there so little revenues, if any?

Does NEOM utilise any systematic management system? Was there any PLANNING work done? Or does NEOM utilise an ad hoc trial and error system?
Was there any Business Plan?
Was there any Financial Plan?
Was there any Marketing Plan?
Was there any planning of any sort done at all, I wonder?

Maybe some will say that there was indeed all these planning done behind the scenes as usual, by some unidentified person.
There does not seem to be the basic PDCA (Plan, Do, Check Act) at all.

In the last three years since I got to know about NEOM and invested in it, NEOM has practically failed in whatever it attempted. Even if they did accomplish something it was not completed on time. Maybe someone can tell us if NEOM had any significant achievement to speak of during the last three years. Sadly, I just cannot think of any!

Whatever it was, I would like to say that was the past. It is now a new year , 2007, with a new management team being gathered, hopefully more professional, more competent and more effective.

It seems that very, very few companies, if any, wants to buy any words yet until they see it working with some value in paying for it. Mind you, NEOM wants to charge a lot of money for the words in Word Registry.

NEOM also seems to be at a loss on how to market Word Registry.

If you were runnung your own business, would you buy into the Word Registry now?

Nik Ellwood, I hope you read this post.

The following article is from E-health Insider. Issue No. 100.

------------------------------------------------------------

Out of hours record systems review ordered by DH
08 Jan 2007



The Department of Health (DH) has instructed all primary care trusts (PCTs) to review the use of paper-based systems by out of hours providers following the case of a patient who died after speaking to eight different out of hours doctors over a bank holiday weekend.

The DH has acted after coroner Andrew Reid wrote to the health sceretary following an inquest into the death of Penny Campbell, a journalist, who died after a series of doctors from the Camidoc out of hours service in north London failed to diagnose that she was developing septicaemia following an injection for haemorrhoids.

It became clear at the inquest that Campbell’s care had been based on a series of handwritten clinical notes rather than an electronic record system and Reid ruled that although there had not been a gross lack of medical attention, crucial clinical information had been missing and "was not always readily available to the last doctor in the chain."

Duncan Selbie, commissioning director for the DH, wrote to strategic health authority chief executives last month to highlight new directions which require every PCT to review the systems currently in operation by out-of-hours providers, particularly where manual processes for recording clinical notes on call sheets are still in operation.

The letter adds: “The directions require PCTs to ensure that arrangements are fit for purpose and assure the continuity of care.”

PCTs are expected to carry out the reviews by the end of this month. Reviews must cover arrangements for how clinical notes are recorded and made accessible to other out of hours health professionals and GPs.

If arrangements are not considered satisfactory, PCTs are instructed to agree changes to the contract with the out of hours provider so that adequate systems are in place or, if that is not possible, PCTs are instructed to impose the requirements. In cases where the PCT itself is the provider trusts are instructed to ensure that adequate arrangements are introduced.

Related stories

System failure

© 2007 E-HEALTH-MEDIA LTD. ALL RIGHTS RESERVED.

---------------------------------------------------------------

Isn't MedifyRemote already available to address such a need for the patient's medical record to be available to the care giver, especially useful for after-hours situations, where access to the patient's electronic medical records by mobile means would be beneficial, if not crucial.

Ian has been CEO since May 2006.

I hope he is not a part of the can of worms.

The reporting of predicted MedifyRemote sales before they are actually closed, took place before Nik came on board, and may have been the doing of whoever wanted to make the sales appear better than they really are, or may have been either Ian's or Jonathan's doing, or both.

Nik just came on board in early December 2006. I just hope he is a man of integrity. I agree that we should give Nik a chance to clean out the can of worms. He needs to make sure he has his worms vaccinations and has good immunity to worms. He has to be well medified against worms, otherwise, with the constant exposure to worms, he runs the risk of turning into a worm himself.

ss9173,

Excellent analysis.

Thank you.

maybank

Please refrain from describing in detail private things in a pubic forum. This is a respectable board. lol

edited : Please excuse any spelling errors

Autonut,

Thanks for sharing your enlightening opinions.

That's why I said this NEOM board has become a CIRCUS.

First time you watch it, you may get impressed by the show. However, you do not want to watch a CIRCUS everyday. Some of the "Big Stars" on this CIRCUS, like "Boast-skill"and even the long respected performer, "Just-Piping", have lost their appeal. "Boast-skill" just keeps repeating his boastful antics and has become irritating to watch, while "Just- Piping" has blown too much hot air in our faces with his frequent piping of hot air. Hot air in one's face is also irritating.

I ran out of IGNORES since my ticket to the CIRCUS is a FREE ticket and you can only IGNORE a maximum of five performers.

If Nik wrote this Week's Bulletin, it is a miserable failure. It communicates practically nothing.

Just what does this tell investors?
"The new Medify Solutions fixed line proposition offers realistic revenue generation opportunities that are not subject to influence by third parties with a proven, profitable model."

Also what does the following tell investors?
"Share price remains unstable, however, it is expected that there will be positive activity surrounding the PPS when the Voice to Voice product is delivered into the market."

What language is this?

capitan, like you, I am absolutely disappointed that this Weekly Investor Bulleting does not give any update at all on the sales of Medify Remote. Instead it creates a diversion and smoke screen by bringing up new sales effort on V2V. This smoke screen is likely an attempt to try to cover up the problems that Nik and his sales people are having with selling Medify Remote.

Nik, lest you forget, Medify Remote is the company's core product, not V2V! Focus your limited resources on the core product and do not be detracted from this focus.

Nik, you will need to better than this in your future Weekly Bulletins.

Because the CIRCUS is still on. I know some parts of the show still carries last year's date. Somehow the show did not end last year, but carried over to this year. The parts of the circus that I do not want to watch, I just IGNORE now. Some of the performers actually are quite skillful and interesting initially, but the repetition of the Boast-skill antics have become simply irritating, so I just IGNORE them now.

This NEOM board is becoming a CIRCUS.

geetar,

Good to hear from you again!

Happy New Year to you!

maybank

Clancy,

I read the following statement from the Investor Relations reply to herbie (refer to herbie's post #15140).

"One of the key learnings to come out of our recent activity is that the sales process is slightly longer than initially perceived. As predicted sales were reported before they were actually closed, this is having a knock-on effect."

This brings me to suspect that MDFY may have also been reporting many other things before they are really concluded. There are many examples that can be cited, like the e-learning business, business in Italy, etc, etc.

Since there is no evidence that the V2V acquisition has indeed been closed conclusively, I suspect this may be another case of "advance reporting", just like, "predicted sales were reported before they were actually closed."

I hope this V2V acquisition really turns out to be a MDFY acquisition, and not someone's else's acquisition.

I fear this may turn out to be an INTEGRITY issue, either as a questionable reporting issue, or worse still, as a questionable acquisition issue.

I think INTEGRITY may have been the biggest question with this company. I hope the VALUES of the new people that have joined MDFY more recently have INTEGRITY as the highest priority.

I am only expressing my fears based on the past experiences from MDFY. I hope my fears will be wrong.

Herbie,

Thanks for re-posting the reply from MDFY.

Looks like the problem is a serious lack of INTEGRITY. Is the problem with JB? Is there an INTEGRITY issue with IO'R?

INTEGRITY is the most important thing in a company and also in a person.


From the MDFY response from Investor Relations (NIK Ellwood's responsibility) it would appear that Nik recognizes the problem with lack of INTEGRITY. I hope he not only recognizes it, but also fixes it. I hope he makes INTEGRITY his highest priority.

I did. Let me re-post that information below:

"The Weekly Investors Bulletin are supposed to be issued on Mondays. In the bulletin issued on Dec 18, MDFY indicated that the next Weekly Investors Bulletin will be issued on Monday 8th January 2007. I guess the gap is due to the Christmas and New Year holidays."

Additionally, please note that to be included in the distribution list please contact investors@medifysolutions.com and title your email “Weekly Bulletin”.


maybank

My best wishes to all MDFY shareholders for a
Happy and Prosperous New Year in 2007.

To MDFY Management, may you set and achieve aggressive 2007 goals for MDFY sales and revenues, profitability and share price that will enable MDFY to be promoted to a major stock exchange like NASDAQ in 2007.

maybank

If you guys got nothing better to post, for goodness sake just keep quiet!

It is important to understand the "Rules" correctly. In such a case, the ex-dividend date is the important date and it applies to both buying and selling.

Buy before the ex-dividend date and you get the extra shares. Sell before the ex-dividend date and you lose the extra shares!
In total, it does not affect the company, only the buyers and sellers of the shares.

maybank

2f2,

What you received is correct. The ex-dividend date was Dec 18, 2006. The number of shares in your account at the opening of market on Dec 18 is the number of shares eligible for the extra shares. Any MDFY shares sold before the ex-dividend date would also lose the eligibility for the extra shares.

Refer to post #14278 with the correct information per the SEC from the link given by herbietheloveblog.
The SEC information is repeated below for easy reference :

Quote:

Sometimes a company pays a dividend in the form of stock rather than cash. The stock dividend may be additional shares in the company or in a subsidiary being spun off. The procedures for stock dividends may be different from cash dividends. The ex-dividend date is set the first business day after the stock dividend is paid (and is also after the record date).

If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend. Your sale includes an obligation to deliver any shares acquired as a result of the dividend to the buyer of your shares, since the seller will receive an I.O.U. or "due bill" from his or her broker for the additional shares. Thus, it is important to remember that the day you can sell your shares without being obligated to deliver the additional shares is not the first business day after the record date, but usually is the first business day after the stock dividend is paid.

If you have questions about specific dividends, you should consult with your financial advisor. You can also get information by going to your library and reading Standard and Poor's Dividend Record Binder.

Unquote


maybank

The Weekly Investors Bulletin are supposed to be issued on Mondays. In the bulletin issued on Dec 18, MDFY indicated that the next Weekly Investors Bulletin will be issued on Monday 8th January 2007. I guess the gap is due to the Christmas and New Year holidays.

maybank

g2285,

I believe today, Dec 26 is a public holiday in UK.

maybank

Thunder,

I agree that on the basis that reputable organisations like Oracle, EMIS and the NHS are engaged with MDFY, the likelihood of MDFY being a scam is less. The issue may not be so much with the company itself, but with certain individual/s who have control of the company. If these individual/s lose their integrity owing to greed, then we have a problem.

Verylong has also pointed out that the market and the company's pps is moved by news and momentum and not just fundamentals alone, which is true. However, in order to hold the gains in the pps, the fundamentals must be good.

I certainly hope that MDFY achieves 60,000 paying customers in much less time than 3 years, perhaps like within a year or 18 months at most. If MDFY achieves at least 5,000 paying customers for MedifyRemote by/before end Mar 2007, that will help to strengthen the fundamentals, which in turn will help to strengthen our hopes and our faith.

MDFY needs to get out of the Pink Sheet domain and move to a major exchange in order to get significant recognition and gains in pps.

As you say, keep the faith! 2007 will be a better year!

Wish all MDFY shareholders,

Merry Christmas and a Happy New Year!

maybank

Geetar,

Any update on the "European Float"?

I am afraid this has "Floated' away!

Personally, I wish MDFY would not think of floating anywhere until it has its feet firmly on the ground in the UK market.

You mentioned the trigger as a pps of $1. What is the significance of the $1 pps? Please advise/clarify. Thanks.

maybank

Regarding your following point:

2) Medify's Company Secretary was a lawyer. Doesn't that make you think that everything has been done to the letter of the law?

Comments:

I just wonder.

Gayle E. Hanlon was Group Company Secretary and Legal Counsel from Aug 1 to Nov 17, 2006.

The following information is from MDFY:

---------------------------------------------------------
Ms. Hanlon, a US business lawyer representing several German and Swiss corporations in their respective international corporate, commercial and IP transactions, will function as Medify Solutions Limited's Group Secretary and Legal Counsel. Ms Hanlon has been entrusted with the management of Medify intellectual property rights, licensing arrangements as well as all commercial and corporate transactions essential for the anticipated introduction of the Medify range of products on a global basis.
The integration of Ms. Hanlon into the Medify Group is part of Medify Solution Limited's expanding infrastructure to ensure the efficient and professional handling of all risk management functions within the corporate group.

------------------------------------------------------------

Ms Hanlon's tenure at MDFY was rather short. I wonder why?

Was it because Ms Hanlon insisted that everything must be done according to the letter of the law?

Was it because she became uncomfortable at MDFY?

Was it because MDFY became uncomfortable with her?

Other reasons?

I just wonder why?

thundermustang,

I believe the figure of 10.75 to 1 is what you calculated as the ratio of the net number of shares you lost as a result of the 1 for 12 reverse split and the recent 5 for 4 split.
I am sorry, but no one I know of has the answer to your question.

However, when MDFY manages to get say, 60,000 paying users for MedifyRemote, there is a very high probabilty that many of us will recover our losses.

Do you think MDFY will be able to achieve 60,000 paying users for MedifyRemote and when will that be?

I believe 2007 will be a better year than 2006.

Merry Christmas and a Happy New Year!

maybank

It is unfortunate that MDFY now does not have sufficient credibility that its potential will be realised soon enough. Until MDFY actually reports a sufficiently high level of real actual revenues, news and momentum may move the stock momentarily, but will not be able to hold the gains. News and Momentum will just create a short term run for certain individuals to sell and then fall back.

Just look at the recent example.
News was released that NHS officially approved the MedifyRemote after the Doncaster PCT pilot run. Shortly after this good news of approval, MDFY followed up and announced the 1 for 4 dividend. This two pieces of news created a short term run up in the price up to $0.40 for a short time and then fell back to a low of $0.09.

For MDFY, News and Momentum, only if coupled with real significant revenues, will then do wonders for investor confidence and the share price will then be able to hold the gains.

This is only a personal opinion. Time will tell.

Verylong,

You wrote,
"It would seem to me that all it would take to get this stock moving properly is to see real revenues coming in."

I agree that sales and revenues are the most crucial factors. However a trickling of sales and revenues will not be enough to move the stock.

First milestone is revenue from 2000 MedifyRemote users which, according to MDFY, is anticipated to take company to a breakeven operation.

Next major milestones would be revenues from at least 40,000 users, perhaps up to 60,000 users if we hope to see MDFY move to a major exchange like NASDAQ or NYSE.

When will MDFY achieve these milestones for MedifyRemote of :
1. 2,000 users
2. 40,000 users
3. 60,000 users

Geetar,

Thanks for your informatives posts. Please continue posting.

Wish you a Merry Christmas and a Happy New Year

maybank

herbie,

Thanks for pointing out the distinction of MOBILE remote access being applicable to MDFY.

maybank

With MDFY being the "sole source" approved by the NHS for the patient care records remote retrieval, IMO, MDFY's highest priority should now be getting sales and consequent revenues and delivering on their commitments to their customers. Do this successfully and the investing community will recognize the true potential of MDFY.

With such achievements in sales and revenues to get the company to be cash flow positive and profitable, great PRs will be a big help to get the word out more effectively.

In the absence of audited sales and revenue achievements, issuing PRs, no matter how great, will still be like pissing in the wind, just like in the past!

I am hopeful that with Nik on board to head the sales and marketing effort, and if he stays diligent and has integrity, we all may still have a chance with MDFY.

maybank